Advertisement

Abdominal Imaging

, Volume 34, Issue 2, pp 193–209 | Cite as

Focal liver lesions: contrast-enhanced ultrasound

  • Tommaso Vincenzo BartolottaEmail author
  • Adele Taibbi
  • Massimo Midiri
  • Roberto Lagalla
Article

Abstract

Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in sonography and it is being increasingly used for the evaluation of focal liver lesions (FLLs). The unique feature of CEUS of non-invasively assessing in real-time liver perfusion throughout the vascular phase has led to a dramatic improvement in diagnostic accuracy of US in either detection or characterization of FLLs, as well as in the guidance and evaluation of response of therapeutic procedures. Currently, CEUS is included as a part of the suggested diagnostic work-up of FLLs, resulting in a better patient management and cost-effective therapy delivering. After a brief description of the basis of different CEUS techniques, contrast-enhancement patterns of different types of benign and malignant FLLs, among hepatic pseudolesions, will be described and discussed on the basis of our experience and literature data. At the same time, the most recent concepts and the use of CEUS in different clinical settings will be presented.

Keywords

Contrast-enhanced sonography Liver neoplasms Ultrasound contrast media Liver  Sonography Liver disease 

References

  1. 1.
    Harvey CJ, Albrecht T (2001) Ultrasound of focal liver lesions. Eur Radiol 11:1578–1593PubMedGoogle Scholar
  2. 2.
    Mergo PJ, Ros PR (1998) Benign lesions of the liver. Radiol Clin North Am 36:319–331PubMedGoogle Scholar
  3. 3.
    Lin ZY, Wang LY, Wang JH, et al.. (1997) Clinical utility of color Doppler sonography in the differentiation of hepatocellular carcinoma, from metastases and hemangioma. J Ultrasound Med 16:51–58PubMedGoogle Scholar
  4. 4.
    Wang LY, Wang JH, Lin ML, et al.. (1997) Hepatic focal nodular hyperplasia: findings on color Doppler ultrasound. Abdom Imaging 22:178–181PubMedGoogle Scholar
  5. 5.
    Tanaka S, Kitamura T, Fujita M, et al. (1990) Color Doppler flow imaging of liver tumors. Am J Roengtenol 154:509–514Google Scholar
  6. 6.
    Lee MG, Auh YH, Cho KS, et al. (1996) Color Doppler flow imaging of hepatocellular carcinoma: comparison with metastatic tumors and hemangiomas by three-step grading for color hues. Clin Imaging 20:199–203PubMedGoogle Scholar
  7. 7.
    Hosten N, Puls R, Bechstein WO, Felix R (1999) Focal liver lesions: Doppler ultrasound. Eur Radiol 9:428–435PubMedGoogle Scholar
  8. 8.
    Uggowitzer MM, Kugler C, Mischinger HJ, et al. (1999) Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med 18:445–451PubMedGoogle Scholar
  9. 9.
    Dill-Macky MJ, Burns PN, Khalili K, Wilson SR (2002) Focal hepatic masses: Enhancement patterns with SH U 508 A and Pulse-Inversion US. Radiology 22: 95–102Google Scholar
  10. 10.
    Bertolotto M, Dalla Palma L, Quaia E, Locatelli M (2000) Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 10:1369–1376PubMedGoogle Scholar
  11. 11.
    Wilson SR, Burns PN (2001) Liver mass evaluation of ultrasound: the impact of microbubble contrast agents and pulse inversion imaging. Semin Liver Dis 21: 147–159PubMedGoogle Scholar
  12. 12.
    Wilson SR, Burns PN, Muradali D, et al. (2000) Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 215:153–161PubMedGoogle Scholar
  13. 13.
    Kim TK, Choi BI, Han JK, et al. (2000) Hepatic tumors: contrast agent-enhancement patterns with Pulse-Inversion harmonic US. Radiology 216:411–417PubMedGoogle Scholar
  14. 14.
    Tanaka S, Ioka T, Oshikawa O, et al. (2001) Dynamic sonography of hepatic tumors. AJR Am J Roengtenol 177:799–805Google Scholar
  15. 15.
    Correas JM, Bridal L, Lesavre A, et al. (2001) Ultrasound contrast agent: properties, principles of action, tolerance, and artefacts. Eur Radiol 11:1316–1328PubMedGoogle Scholar
  16. 16.
    Dalla Palma L, Bertolotto M (1999) Introduction to ultrasound contrast agents: physics overview. Eur Radiol 9(Suppl 3):S338–S342PubMedGoogle Scholar
  17. 17.
    Bouakaz A, de Jong N (2007) WFUMB Safety Symposium on Echo-Contrast Agents: nature and types of ultrasound contrast agents. Ultrasound Med Biol 33:187–196PubMedGoogle Scholar
  18. 18.
    Madjar H, Prömpeler HJ, Del Favero C, et al. (2000) A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound 12:123–130PubMedGoogle Scholar
  19. 19.
    Schneider M (1999) Sono Vue, a new ultrasound contrast agent. Eur Radiol 9(suppl 3):S347–S348PubMedGoogle Scholar
  20. 20.
    Cosgrove D (2006) Ultrasound contrast agents: an overview. Eur J Radiol 60:324–330PubMedGoogle Scholar
  21. 21.
    Quaia E (2007) Microbubble ultrasound contrast agents: an update. Eur Radiol 2007 17:1995–2008Google Scholar
  22. 22.
    Kollmann C (2007) New sonographic techniques for harmonic imaging—underlying physical principles. Eur J Radiol 64:164–172PubMedGoogle Scholar
  23. 23.
    Quaia E (2007) Contrast-specific ultrasound techniques. Radiol Med 112:473–490PubMedGoogle Scholar
  24. 24.
    Leen E (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(suppl 3):E27–E34PubMedGoogle Scholar
  25. 25.
    Lencioni R, Cioni D, Bartolozzi C (2002) Tissue harmonic and contrast agent and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 12:151–65PubMedGoogle Scholar
  26. 26.
    Cosgrove D, Blomley M (2004) Liver tumors: evaluation with contrast-enhanced ultrasound. Abdom Imaging 29:446–454PubMedGoogle Scholar
  27. 27.
    Burns PN, Wilson SR (2007) Focal liver masses: enhancement patterns on contrast-enhanced images—concordance of US scans with CT scans and MR images. Radiology 242:162–174PubMedGoogle Scholar
  28. 28.
    Wilson SR, Kim TK, Jang HJ, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189:W7–W12PubMedGoogle Scholar
  29. 29.
    Ricci P, Laghi A, Cantisani V, et al. (2005) Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol 184:821–827PubMedGoogle Scholar
  30. 30.
    Nicolau C, Brú C (2004) Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 29:348–359PubMedGoogle Scholar
  31. 31.
    Brannigan M, Burns PN, Wilson SR (2004) Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 24:921–935Google Scholar
  32. 32.
    Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast-specific US modes and sulphur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430PubMedGoogle Scholar
  33. 33.
    Solbiati L, Tonolini M, Cova L, Goldberg N (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(suppl 3):E15–E26PubMedGoogle Scholar
  34. 34.
    Catala V, Nicolau C, Vilana R, et al. (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17:1066–1073PubMedGoogle Scholar
  35. 35.
    Li R, Guo Y, Hua X, et al. (2007) Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 35:109–117PubMedGoogle Scholar
  36. 36.
    Bleuzen A, Huang C, Olar M, Tchuenbou J, Tranquart F (2006) Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall Med 27:40–48PubMedGoogle Scholar
  37. 37.
    Quaia E, D’Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M (2006) Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16:1599–1609PubMedGoogle Scholar
  38. 38.
    Larsen LP, Rosenkilde M, Christensen H, et al. (2007) The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol 62:302–307PubMedGoogle Scholar
  39. 39.
    Konopke R, Kersting S, Bergert H, et al. (2007) Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 22:201–207PubMedGoogle Scholar
  40. 40.
    Li R, Guo Y, Hua X, He Y, et al. (2007) Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 35:109–117PubMedGoogle Scholar
  41. 41.
    Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F (2007) New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 39:187–195PubMedGoogle Scholar
  42. 42.
    Lencioni R, European Federation of Societies for Ultrasound in Medicine, Biology (EFSUMB) (2006) Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol 16:1610–1613PubMedGoogle Scholar
  43. 43.
    Rettenbacher T (2007) Focal liver lesions: role of contrast-enhanced ultrasound. Eur J Radiol 64:173–182PubMedGoogle Scholar
  44. 44.
    Wilson SR, Jang HJ, Kim TK, Burns PN (2007) Diagnosis of focal liver masses on ultrasonography: comparison of unenhanced and contrast-enhanced scans. J Ultrasound Med 26:775–787PubMedGoogle Scholar
  45. 45.
    Bartolotta TV, Taibbi A, Galia M, et al. (2007) Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol 17:650–661PubMedGoogle Scholar
  46. 46.
    Lanka B, Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med 26:1703–1714PubMedGoogle Scholar
  47. 47.
    Faccioli N, D’Onofrio M, Comai A, Cugini C (2007) Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med 112:810–820PubMedGoogle Scholar
  48. 48.
    Torzilli G (2005) Adverse effects associated with SonoVue use. Expert Opin Drug Saf 4:399–401PubMedGoogle Scholar
  49. 49.
    Jakobsen JA, Oyen R, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) Safety of ultrasound contrast agents. Eur Radiol 15:941–945PubMedGoogle Scholar
  50. 50.
    Blomley M, Claudon M, Cosgrove D (2007) WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns. Ultrasound Med Biol 33:180–186PubMedGoogle Scholar
  51. 51.
    Dalecki D (2007) WFUMB Safety Symposium on Echo-Contrast Agents: bioeffects of ultrasound contrast agents in vivo. Ultrasound Med Biol 33:205–213PubMedGoogle Scholar
  52. 52.
    Burns PN, Hope Simpson D, Averkiou M (2000) Nonlinear imaging. Ultrasound Med Biol 6:19–22Google Scholar
  53. 53.
    Burns PN, Wilson SR, Simpson DH (2000) Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35:58–71PubMedGoogle Scholar
  54. 54.
    Ros PR, Menu Y, Vilgrain V, et al. (2001) Liver neoplasms and tumor-like conditions. Eur Radiol 11(suppl 2):S145–S165Google Scholar
  55. 55.
    Mortelé KJ, Segatto E, Ros PR. (2004) The infected liver: radiologic-pathologic correlation. Radiographics 24:937–955PubMedGoogle Scholar
  56. 56.
    Czermak BV, Akhan O, Hiemetzberger R, et al. (2007) Echinococcosis of the liver. Abdom Imaging. Oct 3; [Epub ahead of print]Google Scholar
  57. 57.
    Antonopoulos P, Tavernaraki K, Charalampopoulos G, et al. (2007) Hydatid hepatic cysts rupture into the biliary tract, the peritoneal cavity, the thoracic cavity and the hepatic subcapsular space: specific computed tomography findings. Abdom Imaging. Jul 17; [Epub ahead of print]Google Scholar
  58. 58.
    Quaia E, D’Onofrio M, Bartolotta TV, et al. (2005) Characterization of focal liver lesions. In: Quaia E, (eds). Contrast Media in Ultrasonography. Berlin: Springer, pp 125–166Google Scholar
  59. 59.
    Hui JY, Yang MK, Cho DH, et al. (2007) Pyogenic liver abscesses caused by Klebsiella pneumoniae: US appearance and aspiration findings. Radiology 242:769–776PubMedGoogle Scholar
  60. 60.
    Catalano O, Nunziata A, Lobianco R, Siani A. (2005) Real-time harmonic contrast material-specific US of focal liver lesions. Radiographics 25:333–349PubMedGoogle Scholar
  61. 61.
    Catalano O, Sandomenico F, Raso MM, Siani A (2004) Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. AJR Am J Roentgenol 182:447–450PubMedGoogle Scholar
  62. 62.
    Ding H, Wang WP, Huang BJ, et al. (2005) Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 24:285–297PubMedGoogle Scholar
  63. 63.
    Kim KW, Choi BI, Park SH, et al. (2004) Pyogenic hepatic abscesses: distinctive features from hypovascular hepatic malignancies on contrast-enhanced ultrasound with SH U 508A; early experience. Ultrasound Med Biol. 30:725–733PubMedGoogle Scholar
  64. 64.
    Leifer DM, Middleton WD, Teefey SA, Menias CO, Leahy JR (2000) Follow-up of patients at low risk for hepatic malignancy with a characteristic hemangioma at US. Radiology 214:167–72PubMedGoogle Scholar
  65. 65.
    Mirk P, Rubaltelli L, Bazzocchi M, et al. (1982) Ultrasonographic patterns in hepatic hemangiomas. J Clin Ultrasound 10:373–378PubMedGoogle Scholar
  66. 66.
    Farrell MA, Charboneau JW, Reading CC (2000) Sonographic-pathologic correlation of the hyperechoic border of an atypical hepatic hemangioma. J Ultrasound Med 20:169–170Google Scholar
  67. 67.
    Caseiro-Alves F, Brito J, Araujo AE, et al. (2007) Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol 17:1544–1554PubMedGoogle Scholar
  68. 68.
    Moody AR, Wilson SR (1993) Atypical hepatic hemangioma: a suggestive sonographic morphology. Radiology 188:413–417PubMedGoogle Scholar
  69. 69.
    Vilgrain V, Boulous L, Vullierme MP, et al. (2000) Imaging of atypical hemangiomas of the liver with pathological correlation. Radiographics 20:379–397PubMedGoogle Scholar
  70. 70.
    Brancatelli G, Federle MP, Blachar A, et al. (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219:69–74PubMedGoogle Scholar
  71. 71.
    Caturelli E, Pompili M, Bartolucci F, et al. (2001) Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 220: 337–342PubMedGoogle Scholar
  72. 72.
    Perkins AB, Imam K, Smith WJ, Cronan JJ (2000) Color and Power Doppler sonography of liver hemangiomas: a dream unfulfilled? J Clin Ultrasound 28:159–165PubMedGoogle Scholar
  73. 73.
    Bollinger A, Putti P, Barras JP, et al. (1974) Red blood cell velocity in nailfold capillaries of men, measured by a television microscopy technique. Microvasc Res 7:61–72PubMedGoogle Scholar
  74. 74.
    Young LK, Yang WT, Chan KW, et al. (1998) Hepatic hemangiomas: quantitative color power US angiography—facts and fallacies. Radiology 207:51–57PubMedGoogle Scholar
  75. 75.
    Kim TK, Han JK, Kim AY, et al. (1999) Hepatic hemangiomas using a sonographic contrast agent (Levovist) and Power Doppler ultrasonography. J Ultrasound Med 18:737–743PubMedGoogle Scholar
  76. 76.
    Strobel D, Krodel U, Martus P, et al. (2000) Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound 28:1–13PubMedGoogle Scholar
  77. 77.
    Quaia E, Bertolotto M, Dalla Palma L (2002) Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol 12:537–544PubMedGoogle Scholar
  78. 78.
    Bartolotta TV, Midiri M, Galia M, et al. (2003) Atypical liver hemangiomas: contrast enhancement patterns with SH U 508A and pulse-inversion US. Radiol Med 106:320–328PubMedGoogle Scholar
  79. 79.
    Quaia E, Bartolotta TV, Midiri M, et al. (2006) Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on baseline scan. Abdom Imaging 31:59–64PubMedGoogle Scholar
  80. 80.
    Horton KM, Bluemke DA, Hruban RH, et al. (1999) CT and MR imaging of benign hepatic and biliary tumors. Radiographics 19:431–451PubMedGoogle Scholar
  81. 81.
    Semelka RC, Sofka CM (1997) Hepatic hemangiomas. Magn Reson Imaging Clin N Am 5:241–253PubMedGoogle Scholar
  82. 82.
    Bartolotta TV, Midiri M, Quaia E, et al. (2005) Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 15:685–693PubMedGoogle Scholar
  83. 83.
    Jang HJ, Kim TK, Lim HK, et al. (2003) Hepatic hemangioma: atypical appearances on CT, MR imaging and sonography. AJR 180:135–141PubMedGoogle Scholar
  84. 84.
    Coumbaras M, Wendum D, Monnier-Cholley L, Dahan H, Tubiana JM, Arrivé L (2002) CT and MR imaging features of pathologically proven atypical giant hemangiomas of the liver. AJR Am J Roentgenol 179:1457–1463PubMedGoogle Scholar
  85. 85.
    Kato H, Kanematsu M, Matsuo M, Kondo H, Hoshi H (2001) Atypically enhancing hepatic cavernous hemangiomas: high-spatial-resolution gadolinium-enhanced triphasic dynamic gradient-recalled-echo imaging findings. Eur Radiol 11:2510–2515PubMedGoogle Scholar
  86. 86.
    Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y (2001) Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219:699–706PubMedGoogle Scholar
  87. 87.
    Nicolau C, Vilana R, Catalá V, et al. (2006) Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 186:158–167PubMedGoogle Scholar
  88. 88.
    von Herbay A, Vogt C, Häussinger D (2002) Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 179:1273–1279Google Scholar
  89. 89.
    Jang HJ, Kim TK, Wilson SR (2006) Imaging of malignant liver masses: characterization and detection. Ultrasound Q 22:19–29PubMedGoogle Scholar
  90. 90.
    D’Onofrio M, Martone E, Faccioli N, Zamboni G, Malagò R, Mucelli RP (2006) Focal liver lesions: sinusoidal phase of CEUS. Abdom Imaging 31:529–536PubMedGoogle Scholar
  91. 91.
    Wilson SR, Burns PN (2006) An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 186:1401–1412PubMedGoogle Scholar
  92. 92.
    Bartolotta TV, Midiri M, Quaia E, et al. (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643–1649PubMedGoogle Scholar
  93. 93.
    Kim S, Chung JJ, Kim MJ, et al. (2001) Atypical inside-out pattern of hepatic hemangiomas. AJR 174:1571–1574Google Scholar
  94. 94.
    Bartolotta TV, Taibbi A, Galia M, et al. (2007) Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US. Eur J Radiol 64:447–455PubMedGoogle Scholar
  95. 95.
    Cherqui D, Rahmouni A, Charlotte F, et al. (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22:1674–1681PubMedCrossRefGoogle Scholar
  96. 96.
    Herman P, Pugliese V, Machado MA, et al. (2000) Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 24:372–376PubMedGoogle Scholar
  97. 97.
    Pain JA, Gimson AES, Williams R, Howard ER (1991) Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut 32:524–527PubMedGoogle Scholar
  98. 98.
    Belghiti J, Pateron D, Panis Y, et al. (1993) Resection of presumed benign liver tumours. Br J Surg 80:380–383PubMedGoogle Scholar
  99. 99.
    Terkivatan T, de Wilt JH, de Man RA, et al. (2001) Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136:1033–1038PubMedGoogle Scholar
  100. 100.
    Bartolozzi C, Lencioni R, Paolicchi A, et al. (1997) Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography. Eur Radiol 7:1410–1415PubMedGoogle Scholar
  101. 101.
    Golli M, Mathieu D, Anglade MC, et al. (1993) Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology 187:113–117PubMedGoogle Scholar
  102. 102.
    Von Herbay A, Vogt C, Haussinger D. (2002) Pulse Inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 21:1191–1200Google Scholar
  103. 103.
    Yen YH, Wang JH, Lu SN, et al. (2006) Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur J Radiol 60:439–444PubMedGoogle Scholar
  104. 104.
    Ungermann L, Eliás P, Zizka J, Ryska P, Klzo L (2007) Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 63:290–294PubMedGoogle Scholar
  105. 105.
    Bartolotta TV, Midiri M, Scialpi M, Sciarrino E, Galia M, Lagalla R (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14:583–591PubMedGoogle Scholar
  106. 106.
    Brancatelli G, Federle MP, Grazioli L, et al. (2001) Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 219:61–68PubMedGoogle Scholar
  107. 107.
    Hussain SM, Terkivatan T, Zondervan PE, et al. (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24:3–17PubMedGoogle Scholar
  108. 108.
    Vilgrain V, Flejou JF, Arrivé L, et al. (1992) Focal Nodular Hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699–703PubMedGoogle Scholar
  109. 109.
    Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR (2008) Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 190:58–66PubMedGoogle Scholar
  110. 110.
    Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78:704–707PubMedGoogle Scholar
  111. 111.
    Konno K, Ishida H, Sato M, et al. (2001) Liver tumors in fatty liver: difficulty in ultrasonographic interpretation. Abdom Imaging 26:487–491PubMedGoogle Scholar
  112. 112.
    Kim SH, Lee JM, Lee JY, et al. (2005) Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR 184:1077–1084PubMedGoogle Scholar
  113. 113.
    Bartolotta TV, Midiri M, Galia M, et al. (2007) Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion. US Abdom Imaging 32:84–91Google Scholar
  114. 114.
    Colagrande S, Politi LS, Messerini L, et al. (2003) Solitary necrotic nodule of the liver: imaging and correlation with pathologic features. Abdom Imaging 28:41–44PubMedGoogle Scholar
  115. 115.
    Aytac S, Fitoz S, Akyar S, et al. (1999) Focal intrahepatic extramedullary hematopoiesis: color Doppler US and CT findings. Abdom Imaging 24:366–368PubMedGoogle Scholar
  116. 116.
    Wong Y, Chen F, Tai KS, et al. (1999) Imaging features of Focal intrahepatic extramedullary hematopoiesis. Br J Radiol 72:906–910PubMedGoogle Scholar
  117. 117.
    Nam KJ, Kang HK, Lim JH (1996) Inflammatory pseudotumor of the liver: CT and sonographic findings. AJR Am J Roentgenol 167:485–487PubMedGoogle Scholar
  118. 118.
    Gillams A (2007) Minimally invasive treatment for liver and lung metastases in colorectal cancer. BMJ 334:1056–7PubMedGoogle Scholar
  119. 119.
    Garden OJ, Rees M, Poston GJ, et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55(Suppl 3):iii1–8PubMedGoogle Scholar
  120. 120.
    Gillams AR, Lees WR (2005) Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 30:419–426PubMedGoogle Scholar
  121. 121.
    Elvin A, Skogseid B, Hellman P (2005) Radiofrequency ablation of neuroendocrine liver metastases. Abdom Imaging 30:427–434PubMedGoogle Scholar
  122. 122.
    Gillams A, Cassoni A, Conway G, Lees W (2005) Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 30:435–441PubMedGoogle Scholar
  123. 123.
    Piscaglia F, Corradi F, Mancini M, et al. (2007) Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer 7:171PubMedGoogle Scholar
  124. 124.
    Bipat S, van Leeuwen MS, Comans EF, et al. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis—meta-analysis. Radiology 237:123–131PubMedGoogle Scholar
  125. 125.
    Rappeport ED, Loft A, Berthelsen AK, et al. (2007) Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48:369–378PubMedGoogle Scholar
  126. 126.
    Ward J, Robinson PJ, Guthrie JA, et al. (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237:170–180PubMedGoogle Scholar
  127. 127.
    Onishi H, Murakami T, Kim T, et al. (2006) Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 239:131–138PubMedGoogle Scholar
  128. 128.
    Wernecke K, Rummeny E, Bongartz G, et al. (1991) Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol 157:731–739PubMedGoogle Scholar
  129. 129.
    Albrecht T, Hohmann J, Oldenburg A, Skrok J, Wolf KJ (2004) Detection and characterisation of liver metastases. Eur Radiol 14(suppl 8):P25–P33PubMedGoogle Scholar
  130. 130.
    Oldenburg A, Hohmann J, Foert E, et al. (2005) Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 26:277–284PubMedGoogle Scholar
  131. 131.
    Hohmann J, Albrecht T, Oldenburg A, Skrok J, Wolf KJ (2004) Liver metastases in cancer: detection with contrast-enhanced ultrasonography. Abdom Imaging 29:669–681PubMedGoogle Scholar
  132. 132.
    Janica JR, Lebkowska U, Ustymowicz A, et al. (2007) Contrast-enhanced ultrasonography in diagnosing liver metastases. Med Sci Monit 13(suppl 1):111–115PubMedGoogle Scholar
  133. 133.
    Yarmenitis SD, Karantanas A, Bakantaki A, Papantoniou Y, Gourtsoyiannis N (2007) Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: comparison with conventional B-mode ultrasound. Dig Dis 25:86–93PubMedGoogle Scholar
  134. 134.
    Del Frate C, Zuiani C, Londero V, et al. (2003) Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases. AJR Am J Roentgenol 180:1339–1346PubMedGoogle Scholar
  135. 135.
    Sahani DV, Kalva SP, Tanabe KK, et al. (2004) Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology 232:810–814PubMedGoogle Scholar
  136. 136.
    Albrecht T, Blomley MJ, Burns PN, et al. (2003) Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 227:361–370PubMedGoogle Scholar
  137. 137.
    Quaia E, Bertolotto M, Forgács B, Rimondini A, Locatelli M, Mucelli RP (2003) Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol 13:475–483PubMedGoogle Scholar
  138. 138.
    Konopke R, Bunk A, Kersting S (2007) The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 33:1515–1526PubMedGoogle Scholar
  139. 139.
    Murphy-Lavallee J, Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Are metastases really hypovascular in the arterial phase?: the perspective based on contrast-enhanced ultrasonography. J Ultrasound Med 26:1545–1556PubMedGoogle Scholar
  140. 140.
    Fioole B, de Haas RJ, Wicherts DA, Elias SG, et al. (2007) Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol. Apr 27; [Epub ahead of print]Google Scholar
  141. 141.
    Leen E, Ceccotti P, Moug SJ, et al. (2006) Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 243:236–240PubMedGoogle Scholar
  142. 142.
    Torzilli G, Del Fabbro D, Palmisano A, et al. (2005) Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg 9:1148–1153PubMedGoogle Scholar
  143. 143.
    Ong KO, Leen E (2007) Radiological staging of colorectal liver metastases. Surg Oncol 16:7–14PubMedGoogle Scholar
  144. 144.
    McGrane S, McSweeney SE, Maher MM (2007) Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging. Sep 15; [Epub ahead of print]Google Scholar
  145. 145.
    Bhosale P, Szklaruk J, Silverman PM (2006) Current staging of hepatocellular carcinoma: imaging implications. Cancer Imaging 6:83–94PubMedGoogle Scholar
  146. 146.
    Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, Krestin GP (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22:1023–1036PubMedGoogle Scholar
  147. 147.
    Choi BI, Takayasu K, Han MC (1993) Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings. AJR Am J Roentgenol 160:1177–1187PubMedGoogle Scholar
  148. 148.
    Matsui O, Kadoya M, Kameyama T, et al. (1991) Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178:493–497PubMedGoogle Scholar
  149. 149.
    Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E (1999) Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 19:12–18PubMedGoogle Scholar
  150. 150.
    Hayashi M, Matsui O, Ueda K, et al. (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172:969–976PubMedGoogle Scholar
  151. 151.
    Catalano O, Lobianco R, Cusati B, Siani A (2004) Hepatocellular carcinoma: spectrum of contrast-enhanced gray-scale harmonic sonography findings. Abdom Imaging 29:341–347PubMedGoogle Scholar
  152. 152.
    Ogawa S, Kumada T, Toyoda H, et al. (2006) Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen. Eur J Radiol 59:74–81PubMedGoogle Scholar
  153. 153.
    Efremidis SC, Hytiroglou P, Matsui O (2007) Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 17:2969–2982PubMedGoogle Scholar
  154. 154.
    Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244:898–906PubMedGoogle Scholar
  155. 155.
    Nicolau C, Catala V, Vilana R, et al. (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099Google Scholar
  156. 156.
    Strobel D, Kleinecke C, Hänsler J, et al. (2005) Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas—correlation with histological differentiation. Ultraschall Med 26:270–276PubMedGoogle Scholar
  157. 157.
    Fan ZH, Chen MH, Dai Y, Wang, et al. (2006) Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR Am J Roentgenol 186:1512–1519PubMedGoogle Scholar
  158. 158.
    Liu GJ, Xu HX, Lu MD, et al. (2007) Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol 80:321–330PubMedGoogle Scholar
  159. 159.
    Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedGoogle Scholar
  160. 160.
    Kudo M (2006) Early detection and characterization of hepatocellular carcinoma: value of imaging multistep human hepatocarcinogenesis. Intervirology 49:64–69PubMedGoogle Scholar
  161. 161.
    Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236Google Scholar
  162. 162.
    Isozaki T, Numata K, Kiba T, et al. (2003) Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 229:798–805PubMedGoogle Scholar
  163. 163.
    Nicolau C, Vilana R, Bru C (2004) The use of contrast-enhanced ultrasound in the management of the cirrhotic patient and for detection of HCC. Eur Radiol 14(suppl 8):P63–71PubMedGoogle Scholar
  164. 164.
    Tarantino L, Francica G, Sordelli I, et al. (2006) Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging 31:537–544PubMedGoogle Scholar
  165. 165.
    Bartolotta TV, Taibbi A, Midiri M, De Maria M (2007) Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging. Aug 31 [Epub ahead of print]Google Scholar
  166. 166.
    Xu HX, Lu MD, Liu GJ, et al. (2006) Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 25:23–33PubMedGoogle Scholar
  167. 167.
    Bauditz J, Schade T, Wermke W (2007) Sonographic diagnosis of hilar cholangiocarcinomas by the use of contrast agents. Ultraschall Med 28:161–167PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Tommaso Vincenzo Bartolotta
    • 1
    Email author
  • Adele Taibbi
    • 1
  • Massimo Midiri
    • 1
  • Roberto Lagalla
    • 1
  1. 1.Department of RadiologyUniversity of PalermoPalermoItaly

Personalised recommendations